Aspirin-use before ICH: A potentially treatable iatrogenic coagulopathy?

Stroke

Volumn 37, Issue 1, 2006, Pages 4-5

  Tuhrim, Stanley ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1137 ^*  (United States)

Author keywords

Aspirin; Intracerebral hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; WARFARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTICOAGULANT THERAPY; BLOOD CLOTTING DISORDER; BRAIN HEMATOMA; BRAIN HEMORRHAGE; EDITORIAL; HUMAN; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE DYSFUNCTION; BLEEDING; CLINICAL TRIAL; IATROGENIC DISEASE; NOTE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CEREBRAL HEMORRHAGE; CLINICAL TRIALS; HEMORRHAGE; HUMANS; IATROGENIC DISEASE; RISK FACTORS; TREATMENT OUTCOME;

EID: 33644873312     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000196944.24973.f7     Document Type: Editorial

References (13)

1. Gorelick PB, Weisman SM. Risk of hemorrhagic stroke with aspirin use: an update. Stroke. 2005;36:1801-1807.
2. Flibotte JJ, Hagan N. O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064.
3. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med. 2004;164:880-884.
4. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hiibom M. Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129-133.
5. Roque R, Rodriguez Campello A, Gomis M, Ois A, Puente V, Munteis E. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol. 2005;252:412-416.
6. Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000-1004.
7. Mayer SA, Bran NC, Begtrap K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
8. Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965.
9. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
10. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:783-787.
11. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86-91.
12. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461-467.
13. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.